UPDATE 1-AstraZeneca bets on gene editing for broad range of new drugs By: Reuters: Company News January 29, 2015 at 02:35 AM EST * Builds on in-house CRISPR programme at drugmaker (Adds details on collaborations, scientific background) Read More >> Related Stocks: Astrazeneca Plc ADR Thermo Fisher Scientific